Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending January 2013. The report serves as a notification of transactions involving directors, persons discharging managerial responsibility, or connected persons, specifically regarding changes in share interests.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory disclosure of a specific share transaction rather than a financial performance report.
Material Changes
The filing details a specific transaction on January 10, 2013:
- Connected Person: Mrs. K Thomson (connected to Director Mr. P C Thomson).
- Transaction Type: Acquisition of Ordinary Shares via the Company's ShareReward Plan.
- Price: 1381.19 pence per Ordinary Share.
- Volume: Acquisition of 2 Ordinary Shares under the personal contribution element and 2 Ordinary Shares under the matching element (Company contribution).
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the notification of the share transaction in accordance with Disclosure and Transparency Rule 3.1.4R(1)(c).
Investor Verification Points
- Verify the total number of shares held by Mrs. K Thomson post-transaction to assess total exposure.
- Confirm the terms of the ShareReward Plan regarding the matching element contribution.
- Check for any other concurrent filings by Mr. P C Thomson or other directors for the same period.